首页 > 最新文献

Ideggyogyaszati Szemle-Clinical Neuroscience最新文献

英文 中文
[Vanishing white matter disease, a rare leukodystrophy with mutation in the EIF2B5 gene]. [消失的白质病--EIF2B5 基因突变导致的罕见白质营养不良症]。
IF 0.8 4区 医学 Q4 CLINICAL NEUROLOGY Pub Date : 2024-05-30 DOI: 10.18071/isz.77.0207
Gabriella Sinkó, Márton Tompa, Zsuzsanna Kiss, Bernadette Kálmán

Background - Leukodystrophies, a hete­ro­­ge­neous group of brain and spinal cord dis­orders, often pose challenges in es­tab­li­shing molecular etiology. Vanishing White Matter Disease (VWMD) is a rare sub­type of leu­ko­dys­trophies presenting with characteristic clinical and MRI features, ne­ver­theless, achieving diag­nostic certainty requires genetic studies.

Case presentation - Our patient is a nine year old girl, who developed progressive gait difficulties at around 3-4 years of age. Her brain MRI showed confluent lesions with in­­creased signal intensity in the cerebral and cerebellar white matter on T2/FLAIR se­quen­ces, within which hypointense regions ap­peared with signal intensity resembling that of the cerebrospinal fluid on T1 sequences. Whole exome sequencing identified a homozygous likely pathogenic variant within the EIF2B5 gene in the proband, which was present in a heterozygous state in both asymptomatic parents. Having the clinical and molecular genetic diagnosis established, we explored therapeutic possibilities for the patient.

Conclusion - VWMD is a severe form of leukodystrophies with little or no disease modifying therapy available until recently. A better understanding of its molecular pathogenesis offers some hope for new inventive therapies. 

.

背景--白质营养不良症是一类罕见的脑和脊髓疾病,其分子病因学研究往往面临挑战。消失的白质病(VWMD)是一种罕见的白质病亚型,具有特征性的临床和磁共振成像特征,但要确定其诊断需要进行遗传学研究。病例介绍--我们的患者是一名九岁女孩,大约在 3-4 岁时出现进行性步态障碍。她的脑部核磁共振成像(MRI)显示,在T2/FLAIR se­quen­ces上,大脑和小脑白质出现信号强度增高的汇合性病变,在T1序列上出现信号强度与脑脊液相似的低密度区。全外显子组测序在该患者的 EIF2B5 基因中发现了一个可能致病的同源变异体,该变异体在无症状的父母中均以杂合状态存在。在确定了临床和分子遗传学诊断后,我们探讨了对患者进行治疗的可能性。结论 - VWMD 是一种严重的白质营养不良症,直到最近才有或几乎没有改变疾病的疗法。对其分子发病机制的深入了解为新的创新疗法带来了希望。
{"title":"[Vanishing white matter disease, a rare leukodystrophy with mutation in the EIF2B5 gene].","authors":"Gabriella Sinkó, Márton Tompa, Zsuzsanna Kiss, Bernadette Kálmán","doi":"10.18071/isz.77.0207","DOIUrl":"10.18071/isz.77.0207","url":null,"abstract":"<p><p><p style=\"text-align: justify;\"><strong>Background -</strong> Leukodystrophies, a hete&shy;ro&shy;&shy;ge&shy;neous group of brain and spinal cord dis&shy;orders, often pose challenges in es&shy;tab&shy;li&shy;shing&nbsp;molecular etiology. Vanishing White Matter Disease (VWMD) is a rare sub&shy;type of leu&shy;ko&shy;dys&shy;trophies presenting with characteristic clinical and MRI features, ne&shy;ver&shy;theless, achieving diag&shy;nostic certainty requires genetic studies.</p> <p style=\"text-align: justify;\"><strong>Case presentation -</strong> Our patient is a nine year old girl, who developed progressive gait difficulties at around 3-4 years of age. Her brain MRI showed confluent lesions with in&shy;&shy;creased signal intensity in the cerebral and cerebellar white matter on T2/FLAIR se&shy;quen&shy;ces, within which hypointense regions ap&shy;peared with signal intensity resembling that of the cerebrospinal fluid on T1 sequences. Whole exome sequencing identified a homozygous likely pathogenic variant within the EIF2B5 gene in the proband, which was present in a heterozygous state in both asymptomatic parents. Having the clinical and molecular genetic diagnosis established, we explored therapeutic possibilities for the patient.</p> <p style=\"text-align: justify;\"><strong>Conclusion - </strong>VWMD is a severe form of leukodystrophies with little or no disease modifying therapy available until recently. A better understanding of its molecular pathogenesis offers some hope for new inventive therapies.&nbsp;</p>.</p>","PeriodicalId":50394,"journal":{"name":"Ideggyogyaszati Szemle-Clinical Neuroscience","volume":"77 5-6","pages":"207-211"},"PeriodicalIF":0.8,"publicationDate":"2024-05-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141200920","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Angiographic classification of chronic subdural hematoma. 慢性硬膜下血肿的血管造影分类。
IF 0.8 4区 医学 Q4 CLINICAL NEUROLOGY Pub Date : 2024-05-30 DOI: 10.18071/isz.77.0196
Josef Michael Kupka, Patrick Thurner, Tilman Schubert, Nicolin Hainc, Menno Robbert Germans, Zsolt Kulcsár

Background and purpose:

Chronic subdural hematoma (cSDH) is a challenging pathology with high recurrence rate after surgical treatment and may seriously affect the patient’s quality of life. Membrane formation with angiogenesis plays an important role in the evolution of the disease, providing a promising target for endovascular therapy. Our goal is to categorize angiographic patterns of chronic subdural hematoma for standardized reporting purposes.

.

Methods:

In our retrospective analysis of prospective data collection, we analyzed angiographic properties of all high recurrence risk patients with cSDH, who were treated by embolization in our hospital between February 2019 and June 2020. Altogether 17 patients were included in the analysis. 

.

Results:

Based on superselective angiography of the middle meningeal artery (MMA) in the two standard, AP and lateral views, three distinct categories of dural supply were defined: normal vascular pattern (Grade I), cottonwool appearance without enlargement of the MMA branches (Grad II) and strong cottonwool like staining with dilatative remodelling of the MMA branches (Grade III).

.

Conclusion:

The proposed grading system of the angiographic appearance of cSDH, representing the pathophysiological evolution of the disease should be correlated to therapeutic success rates and could be applied in future clinical studies.

.

背景和目的:慢性硬膜下血肿(cSDH)是一种具有挑战性的病理,手术治疗后复发率高,可能严重影响患者的生活质量。伴随血管生成的膜形成在疾病的演变过程中起着重要作用,为血管内治疗提供了一个很有前景的靶点。我们的目标是对慢性硬膜下血肿的血管造影模式进行分类,以便进行标准化报告:在对前瞻性数据收集的回顾性分析中,我们分析了 2019 年 2 月至 2020 年 6 月期间在我院接受栓塞治疗的所有高复发风险 cSDH 患者的血管造影特征。共有 17 名患者被纳入分析:根据脑膜中动脉(MMA)在两个标准AP和侧视图中的超选择血管造影,硬膜供应被定义为三个不同的类别:正常血管形态(I级)、MMA分支无扩大的棉絮状外观(II级)和MMA分支扩张重塑的强棉絮状染色(III级):所提出的 cSDH 血管造影分级系统代表了该疾病的病理生理演变过程,应与治疗成功率相关联,并可应用于未来的临床研究中。
{"title":"Angiographic classification of chronic subdural hematoma.","authors":"Josef Michael Kupka, Patrick Thurner, Tilman Schubert, Nicolin Hainc, Menno Robbert Germans, Zsolt Kulcsár","doi":"10.18071/isz.77.0196","DOIUrl":"https://doi.org/10.18071/isz.77.0196","url":null,"abstract":"<p><strong>Background and purpose: </strong><p>Chronic subdural hematoma (cSDH) is a challenging pathology with high recurrence rate after surgical treatment and may seriously affect the patient&rsquo;s quality of life. Membrane formation with angiogenesis plays an important role in the evolution of the disease, providing a promising target for endovascular therapy. Our goal is to categorize angiographic patterns of chronic subdural hematoma for standardized reporting purposes.</p>.</p><p><strong>Methods: </strong><p>In our retrospective analysis of prospective data collection, we analyzed angiographic properties of all high recurrence risk patients with cSDH, who were treated by embolization in our hospital between February 2019 and June 2020. Altogether 17 patients were included in the analysis.&nbsp;</p>.</p><p><strong>Results: </strong><p>Based on superselective angiography of the middle meningeal artery (MMA) in the two standard, AP and lateral views, three distinct categories of dural supply were defined: normal vascular pattern (Grade I), cottonwool appearance without enlargement of the MMA branches (Grad II) and strong cottonwool like staining with dilatative remodelling of the MMA branches (Grade III).</p>.</p><p><strong>Conclusion: </strong><p>The proposed grading system of the angiographic appearance of cSDH, representing the pathophysiological evolution of the disease should be correlated to therapeutic success rates and could be applied in future clinical studies.</p>.</p>","PeriodicalId":50394,"journal":{"name":"Ideggyogyaszati Szemle-Clinical Neuroscience","volume":"77 5-6","pages":"196-200"},"PeriodicalIF":0.8,"publicationDate":"2024-05-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141200898","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[Az arteria meningea media embolisatio szerepe a krónikus subduralis haematoma kezelési algoritmusában, legújabb evidenciák és saját tapasztalataink]. [动脉脑膜介质栓塞术在治疗慢性硬膜下血肿中的作用、最新证据和我们自己的经验]。
IF 0.8 4区 医学 Q4 CLINICAL NEUROLOGY Pub Date : 2024-05-30 DOI: 10.18071/isz.77.0201
Zsolt Csaba Oláh, Gyula János Papp, Attila Sas, Benedek Oláh, Máté Czabajszki, Béla Demeter

Chronic subdural hematoma is one of the most common diseases requiring a neurosurgical operation that affect elderly and fragile patients. In addition to standard neurosurgical operations (trepanation and craniotomy), embolization of the meningeal artery media is an alternative solution. Several review aerticles have confirmed the very high rate of success and safety of the endovascular treatment. We present the technical details and results of our 10 consecutive selective media meningeal artery embolization procedures for residual chronic subdural hematomas. Our interventions were performed without complications and all resulted in complete recovery. 

.

慢性硬膜下血肿是需要进行神经外科手术的最常见疾病之一,影响着年老体弱的患者。除了标准的神经外科手术(颅骨切开术和开颅手术)外,脑膜动脉介质栓塞也是一种替代解决方案。多篇综述文章证实了血管内治疗的高成功率和安全性。我们介绍了连续 10 例选择性介质脑膜动脉栓塞术治疗残余慢性硬膜下血肿的技术细节和结果。我们的介入治疗无并发症,所有患者均完全康复。
{"title":"[Az arteria meningea media embolisatio szerepe a krónikus subduralis haematoma kezelési algoritmusában, legújabb evidenciák és saját tapasztalataink].","authors":"Zsolt Csaba Oláh, Gyula János Papp, Attila Sas, Benedek Oláh, Máté Czabajszki, Béla Demeter","doi":"10.18071/isz.77.0201","DOIUrl":"10.18071/isz.77.0201","url":null,"abstract":"<p><p><p>Chronic subdural hematoma is one of the most common diseases requiring a neurosurgical operation that affect elderly and fragile patients. In addition to standard neurosurgical operations (trepanation and craniotomy), embolization of the meningeal artery media is an alternative solution. Several review aerticles have confirmed the very high rate of success and safety of the endovascular treatment. We present the technical details and results of our 10 consecutive selective media meningeal artery embolization procedures for residual chronic subdural hematomas. Our interventions were performed without complications and all resulted in complete recovery.&nbsp;</p>.</p>","PeriodicalId":50394,"journal":{"name":"Ideggyogyaszati Szemle-Clinical Neuroscience","volume":"77 5-6","pages":"201-206"},"PeriodicalIF":0.8,"publicationDate":"2024-05-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141200917","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Cognitive impairment in long-COVID. 长期 COVID 患者的认知障碍。
IF 0.8 4区 医学 Q4 CLINICAL NEUROLOGY Pub Date : 2024-05-30 DOI: 10.18071/isz.77.0151
Tozkir Julide, Turkmen Cigdem, Topcular Baris

Background and purpose:

Long Covid is a complex con­dition characterised by symptoms that per­sist for weeks and months after the Co­vid infection, accompanied by cognitive im­pairment that negatively affects daily life. Understanding this complex condition is im­portant for the development of diagnostic and therapeutic strategies.

This article aims to provide a comprehensive overview of cognitive impairment in long-COVID, including its definition, symptoms, pathophysiology, risk factors, assessment tools, imaging abnormalities, potential biomarkers, management strategies, long-term outcomes, and future directions for research.




.

Methods:

The search methodology used in this review aimed to include a wide range of research on cognitive impairment related to both COVID-19 and long-COVID. Systematic searches of PubMed and Google Scholar databases were conducted using a mixture of MeSH terms and keywords including ‘cognition’, ‘cognitive impairment’, ‘brain fog’, ‘COVID-19’ and ‘long-COVID’. The search was restricted to studies published in English between 1 January 2019 and 11 February 2024, which presented findings on neurological manifestations in human participants.

.

Results:

Long-COVID is characterized by persistent symptoms following COVID-19 infection, with cognitive impairment being a prominent feature. Symptoms include brain fog, difficulties with concentration, memory issues, and executive function deficits. Pa­tho­physiological mechanisms involve vi­ral persistence, immune responses, and vas­cular damage. Risk factors include age, pre-existing conditions, and disease seve­rity. Cognitive assessment tools such as the Montreal Cognitive Assessment (MoCA) are essential for diagnosis. Imaging studies, including MRI, PET, and SPECT, reveal structural and functional brain alterations. Potential biomarkers include C-reactive protein, interleukin-6, and neuron-specific enolase. Management strategies encompass cognitive rehabilitation, occupational therapy, medications, and lifestyle modifications.

.

Conclusion:

Long-COVID poses a multifaceted challenge, and cognitive impairment significantly impacts patients’ lives. A multi­disciplinary approach, including cognitive rehabilitation and medication when appropriate, is essential for effective management. Future research should focus on validating biomarkers and understanding long-term cognitive outcomes.

Conclusion – Long-COVID is a global health concern, and cognitive impairment is a distressing symptom. While pharmacological interventions have potential, they require careful consideration. Continued research is crucial for improving the understanding and treatment of cognitive impairment in long-COVID.

.

背景和目的:长Covid是一种复杂的病症,其特点是感染Co­vid后症状持续数周或数月,并伴有认知障碍,对日常生活造成负面影响。了解这种复杂的病症对于制定诊断和治疗策略至关重要。本文旨在全面概述长COVID患者的认知障碍,包括其定义、症状、病理生理学、风险因素、评估工具、影像学异常、潜在的生物标记物、管理策略、长期结果以及未来的研究方向:本综述采用的检索方法旨在纳入与 COVID-19 和 longCOVID 相关的认知障碍方面的广泛研究。在PubMed和Google Scholar数据库中使用MeSH术语和关键词(包括认知、认知障碍、脑雾、COVID-19和longCOVID)进行了系统检索。检索仅限于2019年1月1日至2024年2月11日期间发表的英文研究,这些研究介绍了人类参与者的神经系统表现:长期COVID的特征是感染COVID-19后出现持续性症状,其中认知障碍是一个突出特征。症状包括脑雾、注意力难以集中、记忆问题和执行功能障碍。其生理机制包括病毒持续存在、免疫反应和血管损伤。风险因素包括年龄、原有病症和疾病严重程度。认知评估工具,如蒙特利尔认知评估(MoCA),对于诊断至关重要。核磁共振成像(MRI)、正电子发射计算机断层显像(PET)和 SPECT 等成像研究可揭示大脑结构和功能的改变。潜在的生物标志物包括 C 反应蛋白、白细胞介素-6 和神经元特异性烯醇化酶。管理策略包括认知康复、职业治疗、药物治疗和生活方式调整:长期慢性阻塞性肺疾病给患者带来了多方面的挑战,认知障碍严重影响了患者的生活。多学科方法,包括认知康复和适当的药物治疗,对于有效管理至关重要。未来的研究应侧重于验证生物标志物和了解长期认知结果。结论– 长期慢性阻塞性脑损伤是一个全球性的健康问题,认知障碍是一种令人痛苦的症状。虽然药物干预具有潜力,但需要慎重考虑。继续开展研究对于更好地了解和治疗长期慢性阻塞性脑损伤患者的认知障碍至关重要。
{"title":"Cognitive impairment in long-COVID.","authors":"Tozkir Julide, Turkmen Cigdem, Topcular Baris","doi":"10.18071/isz.77.0151","DOIUrl":"https://doi.org/10.18071/isz.77.0151","url":null,"abstract":"<p><strong>Background and purpose: </strong><p>Long Covid is a complex con&shy;dition characterised by symptoms that per&shy;sist for weeks and months after the Co&shy;vid infection, accompanied by cognitive im&shy;pairment that negatively affects daily life. Understanding this complex condition is im&shy;portant for the development of diagnostic and therapeutic strategies.</p> <p>This article aims to provide a comprehensive overview of cognitive impairment in long-COVID, including its definition, symptoms, pathophysiology, risk factors, assessment tools, imaging abnormalities, potential biomarkers, management strategies, long-term outcomes, and future directions for research.<br><br><br><br><br></p>.</p><p><strong>Methods: </strong><p>The search methodology used in this review aimed to include a wide range of research on cognitive impairment related to both COVID-19 and long-COVID. Systematic searches of PubMed and Google Scholar databases were conducted using a mixture of MeSH terms and keywords including &lsquo;cognition&rsquo;, &lsquo;cognitive impairment&rsquo;, &lsquo;brain fog&rsquo;, &lsquo;COVID-19&rsquo; and &lsquo;long-COVID&rsquo;. The search was restricted to studies published in English between 1 January 2019 and 11 February 2024, which presented findings on neurological manifestations in human participants.</p>.</p><p><strong>Results: </strong><p>Long-COVID is characterized by persistent symptoms following COVID-19 infection, with cognitive impairment being a prominent feature. Symptoms include brain fog, difficulties with concentration, memory issues, and executive function deficits. Pa&shy;tho&shy;physiological mechanisms involve vi&shy;ral persistence, immune responses, and vas&shy;cular damage. Risk factors include age, pre-existing conditions, and disease seve&shy;rity. Cognitive assessment tools such as the Montreal Cognitive Assessment (MoCA) are essential for diagnosis. Imaging studies, including MRI, PET, and SPECT, reveal structural and functional brain alterations. Potential biomarkers include C-reactive protein, interleukin-6, and neuron-specific enolase. Management strategies encompass cognitive rehabilitation, occupational therapy, medications, and lifestyle modifications.</p>.</p><p><strong>Conclusion: </strong><p>Long-COVID poses a multifaceted challenge, and cognitive impairment significantly impacts patients&rsquo; lives. A multi&shy;disciplinary approach, including cognitive rehabilitation and medication when appropriate, is essential for effective management. Future research should focus on validating biomarkers and understanding long-term cognitive outcomes.</p> <p>Conclusion &ndash; Long-COVID is a global health concern, and cognitive impairment is a distressing symptom. While pharmacological interventions have potential, they require careful consideration. Continued research is crucial for improving the understanding and treatment of cognitive impairment in long-COVID.</p>.</p>","PeriodicalId":50394,"journal":{"name":"Ideggyogyaszati Szemle-Clinical Neuroscience","volume":"77 5-6","pages":"151-159"},"PeriodicalIF":0.8,"publicationDate":"2024-05-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141200901","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Statistical evaluation of measured biomechanical properties of human brain aneurysm samples. 人脑动脉瘤样本生物力学特性测量结果的统计评估。
IF 0.8 4区 医学 Q4 CLINICAL NEUROLOGY Pub Date : 2024-05-30 DOI: 10.18071/isz.77.0177
Krisztina Brigitta Tóth, András Lengyel, István Nyáry

Background and purpose:

Human brain aneurysms may often prove fatal if not re­cognized in time and treated accordingly. The understanding of development and rupture of aneurysms can significantly be improved by the application of numerical modelling, which in turn, requires the knowledge of mechanical properties of vessel wall. This study aims to identify assumed differences with respect to age, sex, spatial orientation, and rupture by utilizing detailed statistical analysis of uniaxial tensile measurements of human brain aneurysm samples, performed by the authors in a previous project.

.

Methods:

At surgery of 42 patients, aneu­rysm fundi were cut distally to the clip. In each case, depending on size, varying number of stripes (altogether 88) were prepared and uniaxial stress-strain measurements were performed. Quantities related to the capacity, energy absorption or stiffness were determined and statistically analysed.

.

Results:

The number of specimens in the aneurysm sample was sufficient to establish statistical differences with respect to sex and rupture (p<0.05). No significant differences were detected in orientation, though higher values of stresses and deformations were ob­tained in the circumferential direction com­pared to the meridional direction. 

.

Conclusion:

Significant differences bet­ween sexes with respect to ultimate deformations were demonstrated according to expectation, and the hypothesis on equality of energy capacity could be supported. Similarity of curves with respect to specimen orientation was also observed and ruptured aneurysm sacs tended to be smaller in size. It seems that differences and trends described in this paper are realistic and need to be applied in numerical modelling.

.

背景和目的:人类脑动脉瘤如果不能及时发现并进行相应治疗,往往会导致死亡。应用数值建模可以大大提高对动脉瘤发展和破裂的认识,而数值建模又需要了解血管壁的机械特性。本研究旨在通过对作者在之前的项目中对人类脑动脉瘤样本进行的单轴拉伸测量结果进行详细的统计分析,确定动脉瘤在年龄、性别、空间方位和破裂方面的假定差异:在 42 例患者的手术中,从夹子远端切开动脉瘤基底。根据每个病例的大小,制备了不同数量的条纹(共 88 条),并进行了单轴应力-应变测量。测定并统计分析了与容量、能量吸收或刚度有关的数量:动脉瘤样本的数量足以确定性别和破裂的统计差异(p<0.05)。尽管圆周方向的应力和变形值高于经线方向,但在方向上未发现明显差异:男女之间在极限变形方面的显著差异符合预期,能量容量相同的假设得到支持。此外,还观察到与试样方向有关的曲线相似,破裂的动脉瘤囊往往较小。本文描述的差异和趋势似乎是现实的,需要应用于数值建模。
{"title":"Statistical evaluation of measured biomechanical properties of human brain aneurysm samples.","authors":"Krisztina Brigitta Tóth, András Lengyel, István Nyáry","doi":"10.18071/isz.77.0177","DOIUrl":"https://doi.org/10.18071/isz.77.0177","url":null,"abstract":"<p><strong>Background and purpose: </strong><p>Human brain aneurysms may often prove fatal if not re&shy;cognized in time and treated accordingly. The understanding of development and rupture of aneurysms can significantly be improved by the application of numerical modelling, which in turn, requires the knowledge of mechanical properties of vessel wall. This study aims to identify assumed differences with respect to age, sex, spatial orientation, and rupture by utilizing detailed statistical analysis of uniaxial tensile measurements of human brain aneurysm samples, performed by the authors in a previous project.</p>.</p><p><strong>Methods: </strong><p>At surgery of 42 patients, aneu&shy;rysm fundi were cut distally to the clip. In each case, depending on size, varying number of stripes (altogether 88) were prepared and uniaxial stress-strain measurements were performed. Quantities related to the capacity, energy absorption or stiffness were determined and statistically analysed.</p>.</p><p><strong>Results: </strong><p>The number of specimens in the aneurysm sample was sufficient to establish statistical differences with respect to sex and rupture (p&lt;0.05). No significant differences were detected in orientation, though higher values of stresses and deformations were ob&shy;tained in the circumferential direction com&shy;pared to the meridional direction.&nbsp;</p>.</p><p><strong>Conclusion: </strong><p>Significant differences bet&shy;ween sexes with respect to ultimate deformations were demonstrated according to expectation, and the hypothesis on equality of energy capacity could be supported. Similarity of curves with respect to specimen orientation was also observed and ruptured aneurysm sacs tended to be smaller in size. It seems that differences and trends described in this paper are realistic and need to be applied in numerical modelling.</p>.</p>","PeriodicalId":50394,"journal":{"name":"Ideggyogyaszati Szemle-Clinical Neuroscience","volume":"77 5-6","pages":"177-185"},"PeriodicalIF":0.8,"publicationDate":"2024-05-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141200903","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Lightning strike‑induced cauda equina syndrome: a case report. 雷击诱发马尾综合征:病例报告。
IF 0.8 4区 医学 Q4 CLINICAL NEUROLOGY Pub Date : 2024-03-30 DOI: 10.18071/isz.77.0137
Aysegul Akkan Suzan, Betul Ozenc, Ayse Sahin Gamze, Zeki Odabasi

Peripheral nerve injuries after being struck by lightning have been documented. Here, we report a case of cauda equina syndrome induced by lightning. A 27-year-old man presented with numbness, a burning sensation in the saddle region, and increased urinary urgency after being struck by lightning. He had absent Achilles reflexes and paresthesia in the saddle region upon neurological examination, and magnetic resonance imaging of the spine was normal. Electrophysiological studies indicated involvement of bilateral L5, S1, and S2 myotomes and revealed cauda equina lesions. 
Peripheral nerve injury induced by lightning is rare, and the evaluation of people with neurological complaints using electromyography will help determine the true incidence.

.

有文献记载,被雷击后会造成周围神经损伤。在此,我们报告了一例由雷电诱发的马尾综合征。一名 27 岁的男子被雷击中后出现麻木、鞍区烧灼感和尿急。经神经系统检查,他的跟腱反射消失,鞍区麻木,脊柱磁共振成像正常。电生理检查显示双侧 L5、S1 和 S2 肌束受累,并发现马尾神经损伤。
{"title":"Lightning strike‑induced cauda equina syndrome: a case report.","authors":"Aysegul Akkan Suzan, Betul Ozenc, Ayse Sahin Gamze, Zeki Odabasi","doi":"10.18071/isz.77.0137","DOIUrl":"https://doi.org/10.18071/isz.77.0137","url":null,"abstract":"<p><p><p>Peripheral nerve injuries after being struck by lightning have been documented. Here, we report a case of cauda equina syndrome induced by lightning. A 27-year-old man presented with numbness, a burning sensation in the saddle region, and increased urinary urgency after being struck by lightning. He had absent Achilles reflexes and paresthesia in the saddle region upon neurological examination, and magnetic resonance imaging of the spine was normal. Electrophysiological studies indicated involvement of bilateral L5, S1, and S2 myotomes and revealed cauda equina lesions.&nbsp;<br>Peripheral nerve injury induced by lightning is rare, and the evaluation of people with neurological complaints using electromyography will help determine the true incidence.</p>.</p>","PeriodicalId":50394,"journal":{"name":"Ideggyogyaszati Szemle-Clinical Neuroscience","volume":"77 3-4","pages":"137-139"},"PeriodicalIF":0.8,"publicationDate":"2024-03-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140867134","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[Comparison of pain intensity measurements among patients with low-back pain]. [腰背痛患者疼痛强度测量值的比较]。
IF 0.8 4区 医学 Q4 CLINICAL NEUROLOGY Pub Date : 2024-03-30 DOI: 10.18071/isz.77.0131
Zoltán Nagy, Nóra Kiss, Mátyás Szigeti, Judit Áfra, Norbert Lekka, Ferenc Misik, István Mucsi, Péter Banczerowski

Background and purpose:

Pain intensity is the most frequently assessed health domain in clinical studies among patients with low-back pain. Visual analogue scale (VAS) and Numeric rating scale (NRS) have been the mostly used measurement tools for pain intensity. We proposed to correlate these instruments to a generic health-related quality of life measurement tool in order to show the scale with superior clinical relevance.

.

Methods:

We used cross-sectional, convenience sampling. 120 patients with chronic low-back pain administered the 29-item Patient Reported Outcomes Measurement Information System Profile with NRS included, and the VAS scale in the National Institute of Mental Health, Neurology and Neurosurgery. We determined the correlation between PROMIS domain T-scores and VAS and NRS scores.

.

Results:

We performed Spearman rank correlation test to calculate the correlation coefficient. We found VAS scales measuring pain had weak to moderate correlations with all PROMIS health domains (r = 0.24–0.55). Therefore, we compared correlation of PROMIS domain scores with PROMIS pain intensity numeric rating scale and VAS scales. PROMIS domains had moderate to strong correlations with pain intensity scale (r = 0.45–0.71). PROMIS physical function short form [r = –0.65, 95% CI (–0.75) – (–0.55)] and PROMIS pain interference short form (r = 0.71, 95% CI 0.63 – 0.79) had the strongest correlation with pain intensity item.

.

Conclusion:

NRS has showed greater correlation with PROMIS domain T-scores than VAS scale. This may prove that NRS has greater connection to another health domains, thus it correlated more to health-related quality of life than visual scale. We recommend NRS to use in further clinical studies conducted among patients with low-back pain.

.

背景和目的:在临床研究中,疼痛强度是腰背痛患者最常评估的健康领域。视觉模拟量表(VAS)和数字评分量表(NRS)一直是最常用的疼痛强度测量工具。我们建议将这些工具与通用的健康相关生活质量测量工具相关联,以显示具有更好临床相关性的量表:我们采用了横断面方便抽样法。120 名慢性腰背痛患者使用了包含 NRS 的 29 项患者报告结果测量信息系统简介和国家精神卫生、神经学和神经外科研究所的 VAS 量表。我们确定了 PROMIS 领域 T 分数与 VAS 和 NRS 分数之间的相关性:我们采用斯皮尔曼秩相关检验来计算相关系数。我们发现测量疼痛的 VAS 量表与所有 PROMIS 健康领域都有弱到中等程度的相关性(r = 0.24–0.55)。因此,我们比较了 PROMIS 领域得分与 PROMIS 疼痛强度数字评分量表和 VAS 量表的相关性。PROMIS 各领域与疼痛强度量表(r = 0.45–0.71)具有中度至高度相关性。PROMIS身体功能简表[r = –0.65, 95% CI (–0.75) – (–0.55)] 和PROMIS疼痛干扰简表(r = 0.71, 95% CI 0.63 – 0.79)与疼痛强度项目的相关性最强:与 VAS 量表相比,NRS 与 PROMIS 领域 T 评分的相关性更高。这可能证明了 NRS 与其他健康领域的联系更大,因此它与健康相关生活质量的相关性比视觉量表更高。我们建议在腰背痛患者的进一步临床研究中使用 NRS。
{"title":"[Comparison of pain intensity measurements among patients with low-back pain].","authors":"Zoltán Nagy, Nóra Kiss, Mátyás Szigeti, Judit Áfra, Norbert Lekka, Ferenc Misik, István Mucsi, Péter Banczerowski","doi":"10.18071/isz.77.0131","DOIUrl":"https://doi.org/10.18071/isz.77.0131","url":null,"abstract":"<p><strong>Background and purpose: </strong><p>Pain intensity is the most frequently assessed health domain in clinical studies among patients with low-back pain. Visual analogue scale (VAS) and Numeric rating scale (NRS) have been the mostly used measurement tools for pain intensity. We proposed to correlate these instruments to a generic health-related quality of life measurement tool in order to show the scale with superior clinical relevance.</p>.</p><p><strong>Methods: </strong><p>We used cross-sectional, convenience sampling. 120 patients with chronic low-back pain administered the 29-item Patient Reported Outcomes Measurement Information System Profile with NRS included, and the VAS scale in the National Institute of Mental Health, Neurology and Neurosurgery. We determined the correlation between PROMIS domain T-scores and VAS and NRS scores.</p>.</p><p><strong>Results: </strong><p>We performed Spearman rank correlation test to calculate the correlation coefficient. We found VAS scales measuring pain had weak to moderate correlations with all PROMIS health domains (r = 0.24&ndash;0.55). Therefore, we compared correlation of PROMIS domain scores with PROMIS pain intensity numeric rating scale and VAS scales. PROMIS domains had moderate to strong correlations with pain intensity scale (r = 0.45&ndash;0.71). PROMIS physical function short form [r = &ndash;0.65, 95% CI (&ndash;0.75) &ndash; (&ndash;0.55)] and PROMIS pain interference short form (r = 0.71, 95% CI 0.63 &ndash; 0.79) had the strongest correlation with pain intensity item.</p>.</p><p><strong>Conclusion: </strong><p>NRS has showed greater correlation with PROMIS domain T-scores than VAS scale. This may prove that NRS has greater connection to another health domains, thus it correlated more to health-related quality of life than visual scale. We recommend NRS to use in further clinical studies conducted among patients with low-back pain.</p>.</p>","PeriodicalId":50394,"journal":{"name":"Ideggyogyaszati Szemle-Clinical Neuroscience","volume":"77 3-4","pages":"131-135"},"PeriodicalIF":0.8,"publicationDate":"2024-03-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140854330","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The effect of anesthetic blockade of greater occipital nerve during the withdrawal period of the medication overuse headache treatment. 用药过量头痛治疗停药期对枕大神经的麻醉阻滞效果。
IF 0.8 4区 医学 Q4 CLINICAL NEUROLOGY Pub Date : 2024-03-30 DOI: 10.18071/isz.77.0103
Unsal Aysen Mirac, Aydin Tugrul

Background and purpose:

Discontinua­tion of medication still remains a key element in the treatment of medication overuse headache (MOH), but there is no consensus on the withdrawal procedure. We aimed to share the promising results of anesthetic blockade of greater occipital nerve (GON), which can be an alternative to existing treatments during the early withdrawal period of MOH treatment.

.

Methods:

This study was conducted using regular electronic medical records and headache diaries of patients diagnosed with MOH and treated with anesthetic GON blockade with 0.5% bupivacaine solution in a specia­lized headache outpatient clinic. A total of 86 patients who developed MOH while being followed up for chronic migraine were included in the study.

.

Results:

The treatment schemes for MOH are based on expert consensus and withdrawal strategies are the most challenging part of treatment. In our study, numerical rating scale for headache intensity, overused medication consumption per month, headache frequency (day/month) and the duration of each attack (hour/day) decreased significantly in the first month compared to pre-treatment (p < 0.01). 

.

Conclusion:

Conclusion – Our study suggests that GON blockade can be used as a good alternative therapy in the treatment of MOH.

.

背景和目的:停药仍然是治疗药物过度使用性头痛(MOH)的关键因素,但目前对停药程序尚未达成共识。我们旨在分享大枕神经(GON)麻醉阻滞的良好效果,它可以在MOH治疗的早期停药期替代现有的治疗方法:本研究使用常规电子病历和头痛日记,研究对象是在头痛专科门诊确诊为MOH并接受0.5%布比卡因溶液麻醉阻滞枕大神经治疗的患者。该研究共纳入了86名在慢性偏头痛随访期间患上MOH的患者:MOH的治疗方案基于专家共识,而戒断策略是治疗中最具挑战性的部分。在我们的研究中,头痛强度、每月过度用药量、头痛频率(天/月)和每次发作持续时间(小时/天)的数字评分表在第一个月比治疗前显著下降(p <0.01):结论:我们的研究表明,GON阻断疗法可作为治疗MOH的一种很好的替代疗法。
{"title":"The effect of anesthetic blockade of greater occipital nerve during the withdrawal period of the medication overuse headache treatment.","authors":"Unsal Aysen Mirac, Aydin Tugrul","doi":"10.18071/isz.77.0103","DOIUrl":"https://doi.org/10.18071/isz.77.0103","url":null,"abstract":"<p><strong>Background and purpose: </strong><p>Discontinua&shy;tion of medication still remains a key element in the treatment of medication overuse headache (MOH), but there is no consensus on the withdrawal procedure. We aimed to share the promising results of anesthetic blockade of greater occipital nerve (GON), which can be an alternative to existing treatments during the early withdrawal period of MOH treatment.</p>.</p><p><strong>Methods: </strong><p>This study was conducted using regular electronic medical records and headache diaries of patients diagnosed with MOH and treated with anesthetic GON blockade with 0.5% bupivacaine solution in a specia&shy;lized headache outpatient clinic. A total of 86 patients who developed MOH while being followed up for chronic migraine were included in the study.</p>.</p><p><strong>Results: </strong><p>The treatment schemes for MOH are based on expert consensus and withdrawal strategies are the most challenging part of treatment. In our study, numerical rating scale for headache intensity, overused medication consumption per month, headache frequency (day/month) and the duration of each attack (hour/day) decreased significantly in the first month compared to pre-treatment (p &lt; 0.01).&nbsp;</p>.</p><p><strong>Conclusion: </strong><p>Conclusion &ndash; Our study suggests that GON blockade can be used as a good alternative therapy in the treatment of MOH.</p>.</p>","PeriodicalId":50394,"journal":{"name":"Ideggyogyaszati Szemle-Clinical Neuroscience","volume":"77 3-4","pages":"103-110"},"PeriodicalIF":0.8,"publicationDate":"2024-03-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140869416","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[Thrombolysis treatment and multi- disciplinary management of central retinal artery occlusion in comparison with traditional ophthalmological treatment options]. [视网膜中央动脉闭塞的溶栓治疗和多学科管理与传统眼科治疗方案的比较]。
IF 0.8 4区 医学 Q4 CLINICAL NEUROLOGY Pub Date : 2024-03-30 DOI: 10.18071/isz.77.0089
Szilvia Vajda, Bence Gunda, Krisztina Knézy, Péter Barsi, Csaba Varga, Pál Maurovich-Horvat, Dániel Bereczki, Zsolt Zoltán Nagy

Background and purpose:

The management of central retinal artery occlusion (CRAO) has long been conservative therapy with limited efficacy carried out in ophthalmology departments together with etiolo­gi­cal investigations lacking a standardised protocol. However, CRAO is analogous to ischemic central nervous system stroke and is associated with increased stroke risk, thus, systemic thrombolysis treatment and multidisciplinary management can be beneficial. Since May 2022, at Semmelweis University CRAO patients diagnosed within 4.5 hours are given intravenous thrombolysis therapy and undergo etiologic workup based on current stroke protocols. Here we report our experience with the multidisciplinary, protocol-based management of CRAO in comparison with former non-protocol based ophthalmological conservative treatment.

.

Methods:

We reviewed CRAO patients’ data treated conservatively and with paracentesis within 6 hours at the Department of Ophthalmology between 2013 and 2022 including changes in visual acuity, neurolo­gical and cardiovascular findings compared to those in the thrombolysis project. 

.

Results:

Of the 78 patients receiving non-protocol care, visual improvement was seen in 37% with natural course, 47% with conservative treatment and 47% with paracentesis. Four patients had significant carotid stenosis (2 underwent endarterectomy), 1 carotid dissection, 6 cardioembolism and 1 giant cell arteritis. Of the 4 patients within 4,5 hours, 3 gave their consent to the clinical trial and were treated with thrombolysis and underwent a full etiological assessment. 
2 pa­tients had improved visual acuity, 2 pa­tients had significant carotid stenosis and underwent endarterectomy, 1 patient was started on anticoagulation for newly diagnosed atrial fibrillation.

.

Conclusion:

CRAO patients presenting within 4,5 hours are rare and more patients are needed in our study to establish the efficacy of thrombolysis. However uniform protocollized evaluation helps identifying embolic sources thus, avoiding further and potentially more serious thromboembolic events.

.

背景和目的:长期以来,视网膜中央动脉闭塞(CRAO)的治疗一直是在眼科进行的疗效有限的保守疗法以及缺乏标准化方案的病理检查。然而,CRAO 类似于缺血性中枢神经系统中风,与中风风险增加有关,因此,系统性溶栓治疗和多学科管理是有益的。自 2022 年 5 月起,塞梅尔维斯大学对在 4.5 小时内确诊的 CRAO 患者进行静脉溶栓治疗,并根据现行卒中方案进行病因学检查。在此,我们报告了多学科、基于方案的 CRAO 管理经验,并与以前非基于方案的眼科保守治疗进行了比较:我们回顾了 2013 年至 2022 年期间眼科接受保守治疗和 6 小时内行旁路穿刺术的 CRAO 患者的数据,包括视力、神经和心血管检查结果与溶栓项目患者的对比变化:在接受非协议治疗的78名患者中,37%的患者视力在自然病程中得到改善,47%的患者接受了保守治疗,47%的患者接受了旁路治疗。4名患者有明显的颈动脉狭窄(2人接受了动脉内膜切除术),1人有颈动脉夹层,6人有心肌栓塞,1人有巨细胞动脉炎。在 4.5 小时内就诊的 4 名患者中,3 人同意接受临床试验,接受了溶栓治疗,并接受了全面的病因评估。2 名患者视力得到改善,2 名患者颈动脉明显狭窄,接受了动脉内膜切除术,1 名患者因新诊断的心房颤动开始接受抗凝治疗:在 4.5 小时内就诊的 CRAO 患者很少见,我们的研究需要更多的患者来确定溶栓的疗效。然而,统一的程序化评估有助于确定栓子来源,从而避免进一步发生可能更严重的血栓栓塞事件。
{"title":"[Thrombolysis treatment and multi- disciplinary management of central retinal artery occlusion in comparison with traditional ophthalmological treatment options].","authors":"Szilvia Vajda, Bence Gunda, Krisztina Knézy, Péter Barsi, Csaba Varga, Pál Maurovich-Horvat, Dániel Bereczki, Zsolt Zoltán Nagy","doi":"10.18071/isz.77.0089","DOIUrl":"https://doi.org/10.18071/isz.77.0089","url":null,"abstract":"<p><strong>Background and purpose: </strong><p>The management of central retinal artery occlusion (CRAO) has long been conservative therapy with limited efficacy carried out in ophthalmology departments together with etiolo&shy;gi&shy;cal investigations lacking a standardised protocol. However, CRAO is analogous to ischemic central nervous system stroke and is associated with increased stroke risk, thus, systemic thrombolysis treatment and multidisciplinary management can be beneficial. Since May 2022, at Semmelweis University CRAO patients diagnosed within 4.5 hours are given intravenous thrombolysis therapy and undergo etiologic workup based on current stroke protocols. Here we report our experience with the multidisciplinary, protocol-based management of CRAO in comparison with former non-protocol based ophthalmological conservative treatment.</p>.</p><p><strong>Methods: </strong><p>We reviewed CRAO patients&rsquo; data treated conservatively and with paracentesis within 6 hours at the Department of Ophthalmology between 2013 and 2022 including changes in visual acuity, neurolo&shy;gical and cardiovascular findings compared to those in the thrombolysis project.&nbsp;</p>.</p><p><strong>Results: </strong><p>Of the 78 patients receiving non-protocol care, visual improvement was seen in 37% with natural course, 47% with conservative treatment and 47% with paracentesis. Four patients had significant carotid stenosis (2 underwent endarterectomy), 1 carotid dissection, 6 cardioembolism and 1 giant cell arteritis. Of the 4 patients within 4,5 hours, 3 gave their consent to the clinical trial and were treated with thrombolysis and underwent a full etiological assessment.&nbsp;<br>2 pa&shy;tients had improved visual acuity, 2 pa&shy;tients had significant carotid stenosis and underwent endarterectomy, 1 patient was started on anticoagulation for newly diagnosed atrial fibrillation.</p>.</p><p><strong>Conclusion: </strong><p>CRAO patients presenting within 4,5 hours are rare and more patients are needed in our study to establish the efficacy of thrombolysis. However uniform protocollized evaluation helps identifying embolic sources thus, avoiding further and potentially more serious thromboembolic events.</p>.</p>","PeriodicalId":50394,"journal":{"name":"Ideggyogyaszati Szemle-Clinical Neuroscience","volume":"77 3-4","pages":"89-96"},"PeriodicalIF":0.8,"publicationDate":"2024-03-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140860028","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[Middle meningeal artery embolization to treat acute epidural haematoma, case report and literature review]. [脑膜中动脉栓塞治疗急性硬膜外血肿,病例报告和文献综述]。
IF 0.8 4区 医学 Q4 CLINICAL NEUROLOGY Pub Date : 2024-03-30 DOI: 10.18071/isz.77.0141
Benedek Oláh, Zsolt Csaba Oláh

The treatment of acute epidural haematoma is surgery as soon as possible, elimination of the source of bleeding and evacuation of the haematoma. In case of small epidural haematoma, strict neurological and radiological follow-up is necessary. In a significant percentage of cases, open surgery must also be performed within a few days. In case of small epidural haematomas, embolization of the middle meningeal artery is considered as an alternative solution. We review the literature on middle meningeal artery embolization and present our first treatment. Our case report is the first European report about an acute epidural haematoma which was treated by embolization of middle meningeal artery. Our case study is the first report in which a patient was treated with both open surgery and endovascular treatment for acute epidural haematoma within a year.

.

急性硬膜外血肿的治疗方法是尽快进行手术,消除出血源并清除血肿。对于小的硬膜外血肿,必须进行严格的神经学和放射学随访。在相当一部分病例中,还必须在几天内进行开放手术。对于小硬膜外血肿,脑膜中动脉栓塞术被认为是另一种解决方案。我们回顾了有关脑膜中动脉栓塞术的文献,并介绍了我们的首次治疗。我们的病例报告是欧洲第一份通过脑膜中动脉栓塞治疗急性硬膜外血肿的报告。我们的病例研究是第一份在一年内同时采用开放手术和血管内治疗急性硬膜外血肿的报告。
{"title":"[Middle meningeal artery embolization to treat acute epidural haematoma, case report and literature review].","authors":"Benedek Oláh, Zsolt Csaba Oláh","doi":"10.18071/isz.77.0141","DOIUrl":"https://doi.org/10.18071/isz.77.0141","url":null,"abstract":"<p><p><p>The treatment of acute epidural haematoma is surgery as soon as possible, elimination of the source of bleeding and evacuation of the haematoma. In case of small epidural haematoma, strict neurological and radiological follow-up is necessary. In a significant percentage of cases, open surgery must also be performed within a few days. In case of small epidural haematomas, embolization of the middle meningeal artery is considered as an alternative solution. We review the literature on middle meningeal artery embolization and present our first treatment. Our case report is the first European report about an acute epidural haematoma which was treated by embolization of middle meningeal artery. Our case study is the first report in which a patient was treated with both open surgery and endovascular treatment for acute epidural haematoma within a year.</p>.</p>","PeriodicalId":50394,"journal":{"name":"Ideggyogyaszati Szemle-Clinical Neuroscience","volume":"77 3-4","pages":"141-144"},"PeriodicalIF":0.8,"publicationDate":"2024-03-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140854356","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Ideggyogyaszati Szemle-Clinical Neuroscience
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1